Page last updated: 2024-08-26

bismuth and antofloxacin

bismuth has been researched along with antofloxacin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
He, XJ; Jiang, CS; Li, DZ; Liu, G; Wang, W; Zeng, XP1
He, XJ; Huang, XY; Li, DL; Li, DZ; Liu, G; Wang, W; Wang, XL1

Trials

2 trial(s) available for bismuth and antofloxacin

ArticleYear
Antofloxacin-based bismuth quadruple therapy is safe and effective in Helicobacter pylori eradication: A prospective, open-label, randomized trial.
    Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology, 2021, Volume: 22, Issue:1

    Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Ofloxacin; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome

2021
Comparison of 10 and 14 days of antofloxacin-based versus 14 days of clarithromycin-based bismuth quadruple therapy for Helicobacter pylori eradication: A randomized trial.
    Clinics and research in hepatology and gastroenterology, 2023, Volume: 47, Issue:1

    Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Nausea; Pectins; Proton Pump Inhibitors; Treatment Outcome

2023